Recursion Pharmaceuticals Inc (RXRX) — Tangible Net Worth Ratio
Recursion Pharmaceuticals Inc (RXRX) has a Tangible Net Worth Ratio of 71.3% as of March 2026. This metric is calculated by deducting intangible assets ($294.07 Million) from net assets ($1.02 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See RXRX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Recursion Pharmaceuticals Inc Tangible Net Worth Ratio (2021–2025)
This chart shows how Recursion Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 71.3%, reflecting net assets of $1.02 Billion with intangible assets of $294.07 Million USD. See Recursion Pharmaceuticals Inc (RXRX) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Recursion Pharmaceuticals Inc (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Recursion Pharmaceuticals Inc from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Recursion Pharmaceuticals Inc stock valuation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 72.6% | $1.13 Billion | $309.90 Million | $1.47 Billion | ▲ +5.1 pp |
| 2024 | 67.5% | $1.03 Billion | $335.86 Million | $1.45 Billion | ▼ -24.6 pp |
| 2023 | 92.1% | $463.44 Million | $36.44 Million | $653.70 Million | ▼ -7.6 pp |
| 2022 | 99.7% | $485.81 Million | $1.31 Million | $701.29 Million | ▼ 0.0 pp |
| 2021 | 99.7% | $542.94 Million | $1.39 Million | $610.35 Million | — |